Skip to main content

Digoxin

  • Chapter
  • First Online:
Natural Small Molecule Drugs from Plants

Abstract

Cardiac glycosides, including digoxin, digitoxin, and lanatoside digitalis glycosides, are mainly isolated from lanatoside digitalis. They are used in the treatment of chronic congestive heart failure (CHF) and can also be used to treat some arrhythmia, and they show incomparable advantages in clinical practice. Cardiac glycosides have been used in clinical practice for more than two centuries, which is enough to prove its value. Because they are important agents in the treatment of CHF, the issues of narrow dose span and high-risk poisoning make it a meaningful task to find safer cardiac glycosides. Another important topic for future research is the effect of cardiac glycosides on the treatment of other diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Wilkins RM, Kendall JM, Wade LO. William Withering and digitalis, 1785 to 1985. Br Med J. 1985;290(6461):7–8.

    Article  CAS  Google Scholar 

  2. Lüderitz B. Cardiac glycosides: William Withering (1741–1799). J Interv Card Electrophysiol. 2005;14(1):61–2.

    Article  Google Scholar 

  3. Hui N. The story of the digitalis. Med People. 2001;5:38.

    Google Scholar 

  4. Congratulations on the Chinese academy of sciences institute of medicine for successfully extraction digitoxin. Chin Pharm J. 1954.

    Google Scholar 

  5. Yumen J, Wang X, Yang C, et al. Research progress on pharmacokinetics of cardiac glycosides. Chin Tradit Herb Drug. 2014;45(23):3472–7.

    Google Scholar 

  6. Calderónmontaño JM, Burgosmorón E, Orta ML, et al. Evaluating the cancer therapeutic potential of cardiac glycosides. Biomed Res Int. 2014;2014(12):85–117.

    Google Scholar 

  7. Yang S. Pharmacology. 2nd ed. Beijing: People’s Medical Publishing House; 2010. p. 234–8.

    Google Scholar 

  8. Shen B. Application of cardiac glycoside: experience for the treatment of 128 cases of heart failure. J Pract Med Tech. 2008;15(1):61–2.

    Google Scholar 

  9. Wei YU. Highlights of 2014. Guidelines for diagnosis and treatment of heart failure in China. Chin Clin Dr. 2015;(5):12–14.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Guan-Hua Du .

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Singapore Pte Ltd. and People's Medical Publishing House, PR of China

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Chen, Y., Sun, L., Du, GH. (2018). Digoxin. In: Natural Small Molecule Drugs from Plants. Springer, Singapore. https://doi.org/10.1007/978-981-10-8022-7_8

Download citation

Publish with us

Policies and ethics